{"id":55582,"date":"2026-04-15T16:34:55","date_gmt":"2026-04-15T16:34:55","guid":{"rendered":"https:\/\/my.legal500.com\/developments\/?post_type=press_releases&#038;p=55582"},"modified":"2026-04-15T16:35:03","modified_gmt":"2026-04-15T16:35:03","slug":"shl-medical-ag-secures-refinancing","status":"publish","type":"press_releases","link":"https:\/\/my.legal500.com\/developments\/press-releases\/shl-medical-ag-secures-refinancing\/","title":{"rendered":"SHL Medical AG secures refinancing"},"content":{"rendered":"<p dir=\"auto\"><i>2 April 2026<\/i><\/p>\n<p dir=\"auto\"><strong>Niederer Kraft Frey advised SHL Medical AG on its refinancing by a broad syndicate of lenders led by UBS Switzerland AG as mandated lead arranger, agent and security agent.<\/strong><\/p>\n<p dir=\"auto\"><!--more--><\/p>\n<p dir=\"auto\">Founded in 1989 and headquartered in Switzerland, SHL Medical AG is a world-leading provider of drug delivery solutions, such as autoinjectors, and a trusted partner to global pharmaceutical companies and biotech firms across 75 markets worldwide.<\/p>\n<p dir=\"auto\">The NKF team was led by Transaction partners Adrian Koller and Philip Spoerl\u00e9, working with associate Carlotta Ulmer and junior associate Barbara B\u00fcrgi (both Transactions).<\/p>\n<p dir=\"auto\">\n","protected":false},"featured_media":0,"template":"","class_list":["post-55582","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases\/55582","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/types\/press_releases"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/media?parent=55582"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}